Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been roughly five months since my previous Cardiff Oncology (NASDAQ: CRDF ) article , where I discussed how the company’s flagship drug, onvansertib, could be one of the biggest stories in small-cap oncology in recent memory. IHe is the leader of ...